Yahoo Web Search

Search results

    • Novavax Reports First Quarter 2024 Financial Results and Operational Highlights

      FOX 4 Kansas City· 1 day ago

      ...million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza Combination vaccine trial, which is on-track to initiate second half of 2024, with potential 2026 launch for...